Health Care – FDA: Juul must stop selling vapes

Your Amazon Alexa might someday be able to mimic the voices of your dead relatives, which is about as morbid as it is interesting. Cue “Black Mirror” intro. 

In health care news, Juul’s in trouble after the FDA finally acted on the company’s marketing application.  

Welcome to Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. For The Hill, we’re Peter SullivanNathaniel Weixel and Joseph Choi. Someone forward you this newsletter? Subscribe here.

FDA bans sale of Juul e-cigarettes

The Food and Drug Administration (FDA) said Thursday that it is banning the sale of Juul e-cigarettes, a major blow to the company that was blamed for the youth vaping epidemic.  

  • The agency said Juul did not prove that keeping its products on the market “would be appropriate for the protection of the public health.” 
  • Consumers who already bought and currently use Juul pods won’t be restricted, the FDA said.  

The move is part of a broader FDA review of the vaping industry as the agency decides which products to allow on the market. The FDA has authorized some e-cigarette applications in the past year, but they have not been the products with major market share. 

Safety concerns: The FDA’s action was not related to youth vaping.  

The agency said the marketing denial was because the company provided “insufficient and conflicting data” about potentially harmful chemicals leaching from its e-liquid pods. 

But it’s hard to overlook: FDA Commissioner Robert Califf in a statement indicated Juul “played a disproportionate role in the rise in youth vaping.” 

“Today’s action is further progress on the FDA’s commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public health standards,” Califf said. 

Juul is no longer among the top brands favored by kids, since it no longer sells fruit-flavored cartridges.  According to the government’s annual National Youth Tobacco Survey, fewer than 6 percent of current high school-age youth said they prefer Juul. 

Read more here. 

Panel OKs Moderna two-dose vaccine for kids 6-17

An advisory panel for the Centers for Disease Control and Prevention (CDC) on Thursday gave the green light to Moderna’s vaccine for kids 6-17, bringing it closer to becoming the second vaccine in the U.S. eligible for use in children. 

The CDC’s Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously endorsed Moderna’s vaccine for use in those between the ages of 6 and 17. 

CDC Director Rochelle Walensky is likely to sign off on the committee’s recommendation, as the agency almost always follows ACIP’s endorsements. 

Currently, the only COVID-19 vaccine authorized for use in children between 6 and 17 is Pfizer’s two-dose mRNA vaccine. 

  • Walensky has already signed off on the committee’s previous recommendation that Pfizer’s and Moderna’s coronavirus vaccines be administered to children under the age of 5, with administration of…

Read More: Health Care – FDA: Juul must stop selling vapes

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Live News

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.